Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Crossover Experiments01:16

Crossover Experiments

2.8K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.8K
Longitudinal Research02:20

Longitudinal Research

11.9K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.9K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

121
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
121
Longitudinal Studies01:26

Longitudinal Studies

156
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
156
Experimental Designs01:16

Experimental Designs

11.2K
An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...
11.2K
Censoring Survival Data01:09

Censoring Survival Data

76
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
76

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commentary on "Shaping the future of clinical trials through strategic foresight".

Clinical trials (London, England)·2026
Same author

Why "Minimal Clinically Important Difference" for Interpreting the Magnitude of the Treatment Effect Is Not Useful.

Pharmaceutical statistics·2025
Same author

Sample size formula for a win ratio endpoint.

Statistics in medicine·2022
Same author

Sample size formula for a win ratio endpoint.

Statistics in medicine·2022
Same author

Improving the Standards of Reporting of Clinical Trial Data.

Therapeutic innovation & regulatory science·2020
Same author

Improving the Standards of Reporting of Clinical Trial Data.

Therapeutic innovation & regulatory science·2019
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2025

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
09:12

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats

Published on: March 17, 2019

9.4K

Variable Duration Trial as an Alternative Design for Continuous Endpoints.

Jitendra Ganju1, Julie Guoguang Ma2

  • 1Ganju Clinical Trials, LLC, San Francisco, California, USA.

Pharmaceutical Statistics
|July 12, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces a novel clinical trial design to enhance statistical power without extending trial duration. The proposed method, utilizing variable patient follow-up and a specific statistical analysis, may particularly benefit rare disease research.

Keywords:
continuous endpointsminimum p valuepowervariable duration trials

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.5K
The Power of Interstimulus Interval for the Assessment of Temporal Processing in Rodents
10:27

The Power of Interstimulus Interval for the Assessment of Temporal Processing in Rodents

Published on: April 19, 2019

7.0K

Related Experiment Videos

Last Updated: Jun 21, 2025

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
09:12

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats

Published on: March 17, 2019

9.4K
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.5K
The Power of Interstimulus Interval for the Assessment of Temporal Processing in Rodents
10:27

The Power of Interstimulus Interval for the Assessment of Temporal Processing in Rodents

Published on: April 19, 2019

7.0K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmaceutical Research

Background:

  • Clinical trials with continuous primary endpoints commonly use mixed model repeated measures.
  • Extended follow-up can increase effect size but delays trial completion.
  • Current methods may not fully leverage variable follow-up durations.

Purpose of the Study:

  • To propose an alternative clinical trial design and analysis method to increase statistical power.
  • To avoid extending trial duration or increasing sample size.
  • To offer a potentially more efficient design, especially for rare disease trials.

Main Methods:

  • Implementing a staggered enrollment strategy with variable patient follow-up durations (up to Tmax).
  • Analyzing data using an alpha-adjusted procedure based on p-values from Tmin and Tmax.
  • The proposed analysis method is termed .

Main Results:

  • The method can provide the highest statistical power when powers at Tmin and Tmax are similar.
  • Power is modestly reduced compared to the maximum if Tmin and Tmax powers differ significantly.
  • This design potentially increases statistical power without extending trial duration or sample size.

Conclusions:

  • The proposed trial design and analysis offer a method to enhance statistical power efficiently.
  • This approach is particularly advantageous for rare disease trials with limited patient populations.
  • Variable follow-up and a novel analysis can optimize trial outcomes and resource utilization.